POST Online Media Lite Edition



 

WHO updates emergency use listing for Novavax Nuvaxovid COVID-19 vaccine

Christian Fernsby |
The World Health Organization (WHO) has issued an updated Emergency Use Listing (EUL) for Nuvaxovid (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a primary series of two doses in adolescents aged 12 through 17 and as a booster in adults aged 18 and older.

Article continues below




"Today's updated Emergency Use Listing from the WHO allows us to offer our protein-based vaccine as a primary series to adolescents and as a booster for adults around the world," said Stanley C. Erck, President and Chief Executive Officer, Novavax.

"WHO member countries now have a vaccine option for these indications developed using an innovative approach to traditional technology that can also be stored in standard refrigeration, making it easy to transport."

The updated EUL for Nuvaxovid as a primary series in adolescents aged 12 through 17 was based on data from the ongoing pediatric expansion of the Phase 3 PREVENT-19 trial of 2,232 adolescents aged 12 through 17 years across 75 sites in the U.S., to evaluate the safety and effectiveness of Nuvaxovid.

In the pediatric expansion, Nuvaxovid achieved its primary effectiveness endpoint and demonstrated 80% clinical efficacy overall at a time when the Delta variant was the predominant circulating SARS-CoV-2 strain in the U.S.

Preliminary safety data from the pediatric expansion showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups, and not considered related to the vaccine. Local and systemic reactogenicity was generally lower than or similar to adults, after the first and second dose.

The most common adverse reactions observed were injection site tenderness/pain, headache, myalgia, fatigue, and malaise. There was no increase in reactogenicity in younger (12 to <15 years old) adolescents compared to older (15 to <18 years old) adolescents.

No new safety signal was observed through the placebo-controlled portion of the pediatric expansion.

The updated EUL for Nuvaxovid as a booster in adults aged 18 and older is supported by data from Novavax' Phase 2 trial conducted in Australia, from a separate Phase 2 trial conducted in South Africa, and from the United Kingdom (U.K.)-sponsored COV-BOOST trial.

As part of the Novavax Phase 2 trials, a single booster dose of Nuvaxovid was administered to healthy adult participants approximately six months after their primary two-dose vaccination series of Nuvaxovid. The third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials.

In the COV-BOOST trial, Nuvaxovid induced a meaningful antibody response when used as a heterologous third booster dose.

In the Novavax-sponsored trials, following the booster, local and systemic reactions had a median duration of approximately two days. The incidence of Grade 3 or higher events remained relatively low.

Safety reporting of reactogenicity events showed an increasing incidence across all three doses of Nuvaxovid, often seen with increased immunogenicity. Medically attended adverse events (AE), potentially immune-mediated medical conditions, and severe AEs occurred infrequently following the booster dose and were balanced between vaccine and placebo groups.

In the 12 through 17-year-old population, Novavax' vaccine has been authorized in more than 10 markets including the U.S., the European Union (EU), and the U.K.

The vaccine has also been authorized as a booster in the U.S., EU, Japan, Australia, New Zealand, and Switzerland, and a number of other countries have policy recommendations allowing use of the vaccine as a heterologous or homologous booster dose.

Novavax' vaccine is actively under review in other markets for both indications and has ongoing trials to further explore its efficacy and safety as a booster.

The WHO previously granted EUL for Nuvaxovid in adults aged 18 and older in December 2021.


What to read next

New Zealand grants provisional approval for Novavax COVID-19 booster
Novavax COVID-19 vaccine approved for adolescents in UK
Novavax COVID-19 vaccine granted expanded conditional marketing authorization in EU for booster for 18 and older

CMA CGM launches call for projects worth €200m to step up pace of decarbonization of French shipping

 
The CMA CGM Group has launched a call for projects targeted at startups and businesses working on concrete solutions to step up the pace of decarbonization within all areas of the French shipping industry.
 
 

Latest

Switzerland: 140 million COVID masks set to expire this year
U.S. personal income rises in December 2022, spending falls
Spanish police seize 4.5 tons of cocaine from livestock carrier
Philips Q4 sales EUR 5.4 billion, 4,000 jobs cuts underway

NEWS

Coal train derails in Australia's Queensland state, no injuries

6.1 magnitude earthquake hits northwest China
U.S.: Frigid temperatures for parts of center and west
First international passenger flight takes off from Auckland Airport following deluge
Farmers hold Rail Roko protest in Punjab
Pakistan's anti narcotics force recovers 51 kg drugs, arrests 9
 

BUSINESS

Greece approves construction of floating gas and regasification unit off Athens

Highlights: January 23, 2023 - January 27, 2023
Logistics UK reacts to speculation about part-cancellation of HS2 Project
TABC President: Tunisia can be platform for exporting energy to Europe
Germany faces biggest teacher shortage in 50 years, association says
Electricity from renewable sources on the rise in EU
 

Trending Now

MOL first Japanese company to join First Movers Coalition's shipping sector

Use of neonicotinoids for seeds: France accelerating deployment of alternatives, will support sugar beet sector

Anglo American loads first LNG dual-fuelled vessel in chartered fleet

Ryanair Q3 profit €211m


POLITICS

Argentina, Germany agree to close EU-Mercosur free trade pact ‘soon’

Iran to join Shanghai Cooperation Organization
Iran and Kazakhstan eye increasing annual bilateral trade to $3 billion
Italian Prime Minister in Libya to conclude $8 billion gas deal
EU extends economic sanctions against Russia by six months
Iraq, France agree on energy, security cooperation
 

Today We Recommend

EU launches €100 million Regional Teachers' Initiative for Africa


Highlights 

New York: Zinc8 to relocate, invest $68 million, employ 500

Milo's Tea Company to create 103 new jobs in Spartanburg County, South Carolina

SK Battery America to open U.S. IT center, create 200 high-tech jobs in Roswell, Georgia


COMPANIES

Kern Liebers announces $10 million expansion in Mexico

Alcoa wind projects in Spain get approval
New York: Zinc8 to relocate, invest $68 million, employ 500
FedEx and Penstone inaugurate new plants in Guanajuato, Mexico
MOL first Japanese company to join First Movers Coalition's shipping sector
Socatra to install rotor sails on tanker Alcyone
 

CAREERS

Chiesi appoints Giuseppe Accogli as new group CEO

Foresters Financial Canada president Henry Auyeung to retire
Dollar Bank names Peter Kubiska new chief marketing officer
Bank of South Carolina CEO Fleetwood S. Hassell to retire
Drest appoints Henri Holm as CFO
VC4A introducing Vincent Hoogduijn as CEO
 

ECONOMY

Italy: Business confidence strengthens in January, consumer confidence weakens slightly

Sweden: Economic sentiment deteriorates further in January
U.S. trade deficit for goods soar 8.8% to $90.3b in December
Uzbekistan's economy grows 5.7 pct in 2022
Irish consumer confidence hit seven month high in January
Bank of Canada hikes rates
 

EARNINGS

Provident Bancorp Q4 income $2.7 million

PSB Holding income $4.39 million
Freedom Financial Holdings Q4 income $2,861,940
United Bancorporation of Alabama Q4 income $18.6 million
Pacific West Bancorp Q4 income $561 thousand
Ryanair Q3 profit €211m
 

OP-ED

Micromanaging is the worst enemy of efficiency and teamwork

Niger set to monetize massive gas reserves through Saharan natural gas pipeline
Putting the brakes on EV folly that choked the market
Oil discovery in Kavango Basin may mean huge benefits for Namibians
Cape Town and Dubai battle over Africa's energy future
Is America going to lose its superpower status?
 

AGRIFISH

Ireland: Minister McConalogue opens 2023 Nitrates Derogation applications

Finland confirms conditions and compensation levels of agricultural subsidies
Use of neonicotinoids for seeds: France accelerating deployment of alternatives, will support sugar beet sector
EU Court of Justice: No more derogations for use of bee-toxic neonicotinoids
New swine fever outbreak confirmed in Gauteng, South Africa
Eurostat releases food price monitoring tool
 

LEADERSHIP

Lucky CEO means bad luck for hiring company

Product images could boost food pantry use
The madness of fast service: I want it now!
How to build a resilient brand
Only 32% of employees believe their pay is fair
Corporate duty waivers limit organic company growth and innovation
 

CRIME

EAO issued third fine for Coastal GasLink project

Dutch central bank fines cryptocurrency exchange Coinbase 3.3 mln euros
Bloomberg to pay $5 million for misleading disclosures about its valuation methodologies for fixed income securities
Italy fines Yoox with over 5 million euro for misleading prices and limitations of right of withdrawal
Nexo agrees to pay $45 million in penalties and cease unregistered offering of crypto asset lending product
Virgin Atlantic fined for operating flights in prohibited airspace
 

Magazine

TRAVEL

IntercityHotel Berlin Airport BER opens

Art After School, the perfect way to spark imagination in your child
The world's biggest food fair in Berlin you don't wanna miss
Largest antiques show comes to small Texas town
Meet and see great artists from across the United States
Address Grand Creek Harbour opens its doors to guests
 

SEA, LAND, AIR

Honda Pilot TrailSport, fully equipped SUV with great ground clearance

2024 Corvette E-ray, electrified 4WD
Jaguar I-PACE is now more distinctive
2023 Toyota Prius expected this January
2023 Lincoln Corsair, advance features and ActiveGlide
Lamborghini Huracán Sterrato, first super sports car for any terrain
 

DESIGN

Curved sofas, elegant and gentle

Solios watches, from nature to luxury
Coats of faux fur, but not of faux style
Redifining kitchen space and experience with workstations
Dinning sofas, a soft addition to a modern dinning table
Patchwork carpets, vintage Persian carpets made with unparalleled skill
 

GADGETS

Harman Luxury Audio introduces new JBL Classic Series

KEF KC62, audio excellence and design ingenuity
Panasonic announces flagship OLED TV MZ2000
McIntosh MC451, 150 Watt vacuum tube and 300 Watt solid state amplifier
Headonia 2A3, luxury headphone amplifier that comes with gloves
ASUS launches ExpertBook B9 for executives
 

HEALTH

Indonesia to start rolling out COVID-19 vaccination for children under 6

Ipsen receives CHMP negative opinion for Palovarotene as treatment for fibrodysplasia ossificans progressiva in EU
Once-daily Sotyktu gets positive opinion as treatment for adults with moderate-to-severe plaque psoriasis
EMA update on shortages of antibiotics in EU
Researchers develop new urine test that can diagnose cancer
India launches 'world's first' intranasal COVID-19 vaccine
 

MEANTIME

NASA system predicts small asteroid to pass close by Earth this week

NASA, Pentagon developing nuclear-powered rocket for Mars
Milky Way found to be too big
Earth's inner core rotation paused
Airbus-built JUICE spacecraft set for lift-off to study Jupiter’s icy moons
Ripples in fabric of universe may reveal start of time